Evaluation of the Frequency of Limitation of Activity in Patients With Persistent Asthma (ASMAVIE)

AstraZeneca

Status: Completed

Conditions: Persistent Asthma

Study type: Observational

Funder types: Industry

Identifiers

NCT01078688

NIS-RFR-DUM-2009/2

Details and patient eligibility

About

Evaluation of the frequency of limitation of activity, depending on gender and age-group, in patients with persistent asthma consulting a general practitioner

Enrollment: 1,942 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• persistent asthma receiving long-term maintenance treatment with inhaled steroids (alone or in combination with other drugs)

Exclusion criteria

• Patients with a diagnosis of COPD